The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Signal-transduction cascades as targets for therapeutic intervention by natural products
Abstract
Many bacteria and fungi produce natural products that are toxic to other microorganisms and have a variety of physiological effects in animals. Recent studies have revealed that, in several cases, the targets of these agents are components of conserved signal-transduction cascades. This article looks at the mechanisms of action of five natural products--the immunosuppressants cyclosporin A, FK506 and rapamycin, and the antiproliferative agents wortmannin and geldanamycin. These mechanisms reveal the importance of signal-transduction cascades as targets for therapeutic intervention and the enormous utility of studies of natural-product action in simple model genetic systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Geldanamycin is a natural fermentation product of the benzoquinone ansamycin and inhibits the heat shock protein HSP90 [220], as well show cytotoxic effect against HeLa cells [221].”
From Marine Natural Products: A Source of Novel Anticancer Drugs (2019) · cites this paper as [220]
Citations
Cites
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
Rao, A., Luo, C. H., & Hogan, P. G. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.707 · Cited by 2,592
The mechanism of action of cyclosporin A and FK506
Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,055
Self-citationA mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,665
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
Clipstone, N. A., & Crabtree, G. R. (1992) · Nature · doi:10.1038/357695a0 · Cited by 1,635
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Stebbins, C. E., Russo, A. A., Schneider, C. B., Rosen, N. X., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,370
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
Mitchell, T. G., & Perfect, J. R. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.515 · Cited by 1,213
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.Preprint
Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordán, J., Bellacosa, A., Tsichlis, P. N., & Hay, N. (1997) · Genes & Development · doi:10.1101/gad.11.6.701 · Cited by 1,076
Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k
Jefferies, H. B. J., Fumagalli, S., Dennis, P. B., Reinhard, C., Pearson, R. B., & Thomas, G. (1997) · The EMBO Journal · doi:10.1093/emboj/16.12.3693 · Cited by 934
Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., & Ui, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41901-6 · Cited by 911
Nourse, J. L., Firpo, E. J., Flanagan, W. M., Coats, S., Polyák, K., Lee, M., Massagué, J., Crabtree, G. R., & Roberts, J. M. (1994) · Nature · doi:10.1038/372570a0 · Cited by 889
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
Kunz, J., Henríquez, R., Schneider, U., Deuter‐Reinhard, M., Movva, N. R., & Hall, M. N. (1993) · Cell · doi:10.1016/0092-8674(93)90144-f · Cited by 859
Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin
Brunn, G. J., Hudson, C. C., Sekulić, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, J. C., & Abraham, R. T. (1997) · Science · doi:10.1126/science.277.5322.99 · Cited by 846
FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
O’Keefe, S. J., Tamura, J., Kincaid, R. L., Tocci, M. J., & O’Neill, E. A. (1992) · Nature · doi:10.1038/357692a0 · Cited by 841
X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex
Griffith, J. P., Kim, J. L., Kim, E. E., Sintchak, M. D., Thomson, J. A., Fitzgibbon, M. J., Fleming, M. A., Caron, P. R., Hsiao, K., & Navia, M. A. (1995) · Cell · doi:10.1016/0092-8674(95)90439-5 · Cited by 834
Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complex
Kissinger, C. R., Parge, H. E., Knighton, D. R., Lewis, C. T., Pelletier, L. A., Tempczyk, A., Kalish, V. J., Tucker, K. D., Showalter, R. E., Moomaw, E. W., et al. (1995) · Nature · doi:10.1038/378641a0 · Cited by 768
Hartley, K. O., Gell, D. A., Smith, G. C. M., Zhang, H., Divecha, N., Connelly, M. A., Admon, A., Lees‐Miller, S. P., Anderson, C. W., & Jackson, S. P. (1995) · Cell · doi:10.1016/0092-8674(95)90482-4 · Cited by 745
Yano, H., Nakanishi, S., Kimura, K. D., Hanai, N., Saitoh, Y., Fukui, Y., Nonomura, Y., & Matsuda, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74466-4 · Cited by 725
Brunn, G. J., Williams, J. M., Sabers, C. J., Wiederrecht, G., Lawrence, J. C., & Abraham, R. T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00911.x · Cited by 715
Control of p70 S6 kinase by kinase activity of FRAP in vivo
Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Shin, T. B., & Schreiber, S. L. (1995) · Nature · doi:10.1038/377441a0 · Cited by 705
Wymann, M. P., Bulgarelli-Leva, G., Zvelebil, M., Pirola, L., Vanhaesebroeck, B., Waterfield, M. D., & Panayotou, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1722 · Cited by 679
Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal Transduction
SIGAL, N. H., & Dumont, F. J. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.002511 · Cited by 662
Stephens, L., Smrcka, A. V., Cooke, F. T., Jackson, T., Sternweis, P. C., & Hawkins, P. T. (1994) · Cell · doi:10.1016/0092-8674(94)90237-2 · Cited by 595
Regulation of eIF-4E BP1 Phosphorylation by mTOR
Hara, K., Yonezawa, K., Kozlowski, M. T., Sugimoto, T., Andrabi, K. I., Weng, Q.-P., Kasuga, M., Nishimoto, I., & Avruch, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26457 · Cited by 522
Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase
Ui, M., Okada, T., Hazeki, K., & Hazeki, O. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89056-8 · Cited by 520
Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
Ahmed, N. N., Grimes, H. L., Bellacosa, A., Chan, T. O., & Tsichlis, P. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3627 · Cited by 519
Calcineurin is required for virulence of Cryptococcus neoformans
Odom, A., Muir, S., Lim, E., Toffaletti, D. L., Perfect, J., & Heitman, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2576 · Cited by 516
Self-citationScott, P., Brunn, G. J., Kohn, A. D., Roth, R. A., & Lawrence, J. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7772 · Cited by 482
RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.
Chiu, M. I., Katz, H., & Berlin, V (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12574 · Cited by 481
Schulte, T. W., Blagosklonny, M. V., Ingui, C., & Neckers, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24585 · Cited by 457
Okada, T., Sakuma, L., Fukui, Y., Hazeki, O., & Ui, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41900-4 · Cited by 439
Wortmannin, a microbial product inhibitor of myosin light chain kinase.
Nakanishi, S., Kakita, S., TAKAHASHI, I., Kawahara, K., TSUKUDA, E., Sano, T., Yamada, K., Yoshida, M., Kase, H., & Matsuda, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45857-7 · Cited by 430
Helliwell, S. B., Wagner, P., Kunz, J., Deuter‐Reinhard, M., Henríquez, R., & Hall, M. N. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.1.105 · Cited by 390
A Signaling Pathway to Translational Control
Brown, E. J., & Schreiber, S. L. (1996) · Cell · doi:10.1016/s0092-8674(00)80125-7 · Cited by 364
Miyazaki, T., Liu, Z., Kawahara, A., Minami, Y., Yamada, K., Tsujimoto, Y., Barsoumian, E. L., Perlmutter, R. M., & Taniguchi, T. (1995) · Cell · doi:10.1016/0092-8674(95)90332-1 · Cited by 362
Cafferkey, R., Young, P. R., McLaughlin, M. M., Bergsma, D. J., Koltin, Y., Sathe, G. M., Faucette, L. F., Eng, W.-K., Johnson, R. K., & Livi, G. P. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6012-6023.1993 · Cited by 309
Zheng, X.-F., Fiorentino, D. F., Chen, J., Crabtree, G. R., & Schreiber, S. L. (1995) · Cell · doi:10.1016/0092-8674(95)90058-6 · Cited by 300
DIFFERENTIAL SIGNALING BY LYMPHOCYTE ANTIGEN RECEPTORS
Alberola‐Ila, J., Takaki, S., Kerner, J. D., & Perlmutter, R. M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.125 · Cited by 260
Stack, J. H., & Emr, S. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31729-0 · Cited by 244
TOR Mutations Confer Rapamycin Resistance by Preventing Interaction with FKBP12-Rapamycin
Lorenz, M. C., & Heitman, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27531 · Cited by 236
Self-citationvon Manteuffel, S. R., Gingras, A., Ming, X., Sonenberg, N., & Thomas, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4076 · Cited by 235
de Groot, R. P., Ballou, L. M., & Sassone‐Corsi, P. (1994) · Cell · doi:10.1016/0092-8674(94)90402-2 · Cited by 232
Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro.
Shi, Y., Frankel, A., Radvanyi, L. G., Penn, L. Z., Miller, R. G., & Mills, G. B. (1995) · PubMed · Cited by 225
A Cyclophilin Function in Hsp90-Dependent Signal Transduction
Duina, A. A., Foreman, H.-C. C., Marsh, J. A., Lindquist, S. L., & Gaber, R. F. (1996) · Science · doi:10.1126/science.274.5293.1713 · Cited by 224
Rapamycin Resistance Tied to Defective Regulation of p27 Kip1
Luo, Y., Marx, S. O., Kiyokawa, H., Koff, A., Massagué, J., & Marks, A. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6744 · Cited by 210
Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from α-factor arrest in yeast
Poor, F., Parent, S. A., Morin, N. R., Dahl, A., Ramadan, N., Chrebet, G. L., Bostian, K. A., & NIELSEN, J. B. K. (1992) · Nature · doi:10.1038/360682a0 · Cited by 192
Cloning and Characterization of a Wortmannin-sensitive Human Phosphatidylinositol 4-Kinase
Meyers, R. E., & Cantley, L. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4384 · Cited by 172
John, A. R. O., Poeta, M. D., Perfect, J. R., & Heitman, J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.156 · Cited by 153
Self-citationInteraction between FKBP12-rapamycin and TOR involves a conserved serine residue.
Stan, R., McLaughlin, M. M., Cafferkey, R., Johnson, R. K., Rosenberg, M. J., & Livi, G. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31592-8 · Cited by 143
Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains.
Breuder, T., Hemenway, C. S., Movva, N. R., Cardenas, M. E., & Heitman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5372 · Cited by 135
Self-citationCardenas, M. E., & Heitman, J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00277.x · Cited by 117
Self-citationA comparison of demethoxyviridin and wortmannin as inhibitors of phosphatidylinositol 3‐kinase
Woscholski, R., Kodaki, T., McKinnon, M., Waterfield, M. D., & Parker, P. J. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80482-6 · Cited by 115
Cloning and characterization of a human phosphatidylinositol 4-kinase.
Wong, K., & Cantley, L. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61989-7 · Cited by 98
The Rapamycin and FKBP12 Target (RAFT) Displays Phosphatidylinositol 4-Kinase Activity
Sabatini, D. M., Pierchala, B. A., Barrow, R. K., Schell, M. J., & Snyder, S. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.20875 · Cited by 82
Ferby, I., Waga, I., Hoshino, M., Kume, K., & Shimizu, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.11684 · Cited by 79
Cutler, N. S., Heitman, J., & Cardenas, M. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27671 · Cited by 78
Self-citationGolgi Localization in Yeast Is Mediated by the Membrane Anchor Region of Rat Liver Sialyltransferase
Schwientek, T., Lorenz, C., & Ernst, J. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5483 · Cited by 73
Hemenway, C. S., Dolinski, K. J., Cardenas, M. E., Hiller, M. A., Jones, E. W., & Heitman, J. (1995) · Genetics · doi:10.1093/genetics/141.3.833 · Cited by 62
Self-citationRotonda, J., Burbaum, J. J., Chan, H., Marcy, A. I., & Becker, J. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52995-1 · Cited by 61
Rotonda, J., Burbaum, J. J., Chan, H., et al. (1993) · PubMed · doi:10.2210/pdb1yat/pdb · Cited by 53
Zhu, D., Cardenas, M. E., & Heitman, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24831 · Cited by 42
Self-citationMammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.Preprint
Alarcón, C. M., Cardenas, M. E., & Heitman, J. (1996) · Genes & Development · doi:10.1101/gad.10.3.279 · Cited by 42
Self-citationCalcineurin mutants render T lymphocytes resistant to cyclosporin A.
Zhu, D., Cardenas, M. E., & Heitman, J. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09301-0 · Cited by 35
Self-citationCardenas, M. E., Lorenz, M. C., Hemenway, C. S., & Heitman, J. (1994) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171739 · Cited by 34
Self-citationCardenas, M. E., Lim, E. Q., & Heitman, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.20997 · Cited by 34
Self-citationEffects of rapamycin on apoptosis of rheumatoid synovial cells
Migita, K., Eguchi, K., Ichinose, Y., Kawabe, Y., Tsukada, T., Aoyagi, T., & Nagataki, S. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.d01-1002.x · Cited by 25
Yang, M., Wu, W., & Mirocha, C. J. (1996) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979609052756 · Cited by 8
Research works printed but not linked: 4
- Heitman, 1992, New Biol., 4, 448
- Zhu, 1996, Mol. Pharmacol., 50, 506
- Cafferkey, 1993, Mol. Cell. Biol., 13, 6012, 10.1128/MCB.13.10.6012 · DOI
- Shi, 1995, Cancer Res., 55, 1982
Cited by
Sorted by citations
Microbial drug discovery: 80 years of progress
Demain, A. L., & Sánchez, S. (2009) · The Journal of Antibiotics · doi:10.1038/ja.2008.16 · Cited by 1,004
Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
Semenza, G. L. (2000) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230091169186 · Cited by 657
Natural products in anticancer therapy
Ab, D. R. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00063-7 · Cited by 618
SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling
Blake, R. A., Broome, M. A., Liu, X., Wu, J., Gishizky, M. L., Sun, L., & Courtneidge, S. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.9018-9027.2000 · Cited by 580
The TOR signaling cascade regulates gene expression in response to nutrientsPreprint
Cardenas, M. E., Cutler, N. S., Lorenz, M. C., Como, C. J. D., & Heitman, J. (1999) · Genes & Development · doi:10.1101/gad.13.24.3271 · Cited by 580
Self-citation
Metadata
- Authors
- Cardenas, M. E., Sanfridson, A., Cutler, N. S., & Heitman, J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Heitman, Joseph
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 1998-10
- Volume
- 16
- Issue
- 10
- Pages
- 427-433
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W1968232511
- Cited by
- 101
- References
- 72
- Citations by year
- 2023: 1 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 1 · 2014: 7 · 2013: 3 · 2012: 1
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ai041937-03, 5k01ca077075-04)
- National Cancer Institute (KO1 CA77075)
- National Institute of Allergy and Infectious Diseases (AI 39115, AI41937)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- signaling pathways, natural products, microbial secondary metabolites, cyclosporine, FK506, rapamycin, wortmannin, geldanamycin, immunosuppressants, antiproliferative agents, mechanism of action, target-based drug discovery
- MeSH terms
- Wortmannin, Androstadienes, Animals, Cell Cycle, Enzyme Inhibitors, Fungi, Humans, Immunosuppressive Agents, Quinones, Protein Biosynthesis, Signal Transduction, Benzoquinones, Tacrolimus, Cyclosporine, Apoptosis, HSP90 Heat-Shock Proteins, Calcineurin, Sirolimus, Lactams, Macrocyclic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review